In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, IGM Biosciences Inc (NASDAQ: IGMS) closed at $14.50 down -12.33% from its previous closing price of $16.54. In other words, the price has decreased by -$12.33 from its previous closing price. On the day, 1.55 million shares were traded. IGMS stock price reached its highest trading level at $15.25 during the session, while it also had its lowest trading level at $11.3.
Ratios:
For a deeper understanding of IGM Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.06 and its Current Ratio is at 7.06. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.27.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on October 01, 2024, Downgraded its rating to Hold and sets its target price to $12 from $24 previously.
On October 01, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also lowered its target price recommendation from $12 to $9.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on February 09, 2024, whereas the target price for the stock was revised from $9 to $21.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 13 ’24 when Weber Steven sold 469 shares for $11.54 per share. The transaction valued at 5,412 led to the insider holds 25,543 shares of the business.
Takimoto Chris H sold 1,487 shares of IGMS for $17,158 on Sep 13 ’24. The CHIEF MEDICAL OFFICER now owns 154,331 shares after completing the transaction at $11.54 per share. On Sep 13 ’24, another insider, Tahir Misbah, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 1,487 shares for $11.54 each. As a result, the insider received 17,158 and left with 122,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGMS now has a Market Capitalization of 860121152 and an Enterprise Value of 643112704. For the stock, the TTM Price-to-Sale (P/S) ratio is 295.58 while its Price-to-Book (P/B) ratio in mrq is 7.02. Its current Enterprise Value per Revenue stands at 220.925 whereas that against EBITDA is -2.841.
Stock Price History:
Over the past 52 weeks, IGMS has reached a high of $22.50, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is 25.06%, while the 200-Day Moving Average is calculated to be 42.13%.
Shares Statistics:
For the past three months, IGMS has traded an average of 322.74K shares per day and 550270 over the past ten days. A total of 33.18M shares are outstanding, with a floating share count of 20.90M. Insiders hold about 64.77% of the company’s shares, while institutions hold 37.40% stake in the company. Shares short for IGMS as of 1726185600 were 5281262 with a Short Ratio of 16.36, compared to 1723680000 on 5781970. Therefore, it implies a Short% of Shares Outstanding of 5281262 and a Short% of Float of 35.05.
